Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2003 Mar 1;370(Pt 2):729–735. doi: 10.1042/BJ20021710

Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques.

Alan A Woods 1, Stuart M Linton 1, Michael J Davies 1
PMCID: PMC1223198  PMID: 12456264

Abstract

Oxidation is believed to play a role in atherosclerosis. Oxidized lipids, sterols and proteins have been detected in early, intermediate and advanced human lesions at elevated levels. The spectrum of oxidized side-chain products detected on proteins from homogenates of advanced human lesions has been interpreted in terms of the occurrence of two oxidative mechanisms, one involving oxygen-derived radicals catalysed by trace transition metal ions, and a second involving chlorinating species (HOCl or Cl2), generated by the haem enzyme myeloperoxidase (MPO). As MPO is released extracellularly by activated monocytes (and possibly macrophages) and is a highly basic protein, it would be expected to associate with polyanions such as the glycosaminoglycans of the extracellular matrix, and might result in damage being localized at such sites. In this study proteins extracted from extracellular matrix material obtained from advanced human atherosclerotic lesions are shown to contain elevated levels of oxidized amino acids [3,4-dihydroxyphenylalanine (DOPA), di-tyrosine, 2-hydroxyphenylalanine ( o-Tyr)] when compared with healthy (human and pig) arterial tissue. These matrix-derived materials account for 83-96% of the total oxidized protein side-chain products detected in these plaques. Oxidation of matrix components extracted from healthy artery tissue, and model proteins, with reagent HOCl is shown to give rise to a similar pattern of products to those detected in advanced human lesions. The detection of elevated levels of DOPA and o-Tyr, which have been previously attributed to the occurrence of oxygen-radical-mediated reactions, by HOCl treatment, suggests an alternative route to the formation of these materials in plaques. This is believed to involve the formation and subsequent decomposition of protein chloramines.

Full Text

The Full Text of this article is available as a PDF (228.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blumenkrantz N., Asboe-Hansen G. New method for quantitative determination of uronic acids. Anal Biochem. 1973 Aug;54(2):484–489. doi: 10.1016/0003-2697(73)90377-1. [DOI] [PubMed] [Google Scholar]
  2. Bolton E. J., Jessup W., Stanley K. K., Dean R. T. Enhanced LDL oxidation by murine macrophage foam cells and their failure to secrete nitric oxide. Atherosclerosis. 1994 Apr;106(2):213–223. doi: 10.1016/0021-9150(94)90126-0. [DOI] [PubMed] [Google Scholar]
  3. Carr A. C., Myzak M. C., Stocker R., McCall M. R., Frei B. Myeloperoxidase binds to low-density lipoprotein: potential implications for atherosclerosis. FEBS Lett. 2000 Dec 29;487(2):176–180. doi: 10.1016/s0014-5793(00)02227-4. [DOI] [PubMed] [Google Scholar]
  4. Daphna E. M., Michaela S., Eynat P., Irit A., Rimon S. Association of myeloperoxidase with heparin: oxidative inactivation of proteins on the surface of endothelial cells by the bound enzyme. Mol Cell Biochem. 1998 Jun;183(1-2):55–61. doi: 10.1023/a:1006848730927. [DOI] [PubMed] [Google Scholar]
  5. Daugherty A., Dunn J. L., Rateri D. L., Heinecke J. W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest. 1994 Jul;94(1):437–444. doi: 10.1172/JCI117342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Davies M. J., Fu S., Wang H., Dean R. T. Stable markers of oxidant damage to proteins and their application in the study of human disease. Free Radic Biol Med. 1999 Dec;27(11-12):1151–1163. doi: 10.1016/s0891-5849(99)00206-3. [DOI] [PubMed] [Google Scholar]
  7. Dean R. T., Fu S., Stocker R., Davies M. J. Biochemistry and pathology of radical-mediated protein oxidation. Biochem J. 1997 May 15;324(Pt 1):1–18. doi: 10.1042/bj3240001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dunlop Rachael A., Rodgers Kenneth J., Dean Roger T. Recent developments in the intracellular degradation of oxidized proteins. Free Radic Biol Med. 2002 Oct 1;33(7):894–906. doi: 10.1016/s0891-5849(02)00958-9. [DOI] [PubMed] [Google Scholar]
  9. Fu S. L., Dean R. T. Structural characterization of the products of hydroxyl-radical damage to leucine and their detection on proteins. Biochem J. 1997 May 15;324(Pt 1):41–48. doi: 10.1042/bj3240041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fu S., Davies M. J., Stocker R., Dean R. T. Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem J. 1998 Aug 1;333(Pt 3):519–525. doi: 10.1042/bj3330519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fu S., Hick L. A., Sheil M. M., Dean R. T. Structural identification of valine hydroperoxides and hydroxides on radical-damaged amino acid, peptide, and protein molecules. Free Radic Biol Med. 1995 Sep;19(3):281–292. doi: 10.1016/0891-5849(95)00021-o. [DOI] [PubMed] [Google Scholar]
  12. Fu S., Wang H., Davies M., Dean R. Reactions of hypochlorous acid with tyrosine and peptidyl-tyrosyl residues give dichlorinated and aldehydic products in addition to 3-chlorotyrosine. J Biol Chem. 2000 Apr 14;275(15):10851–10858. doi: 10.1074/jbc.275.15.10851. [DOI] [PubMed] [Google Scholar]
  13. Goldstein J. L., Basu S. K., Brown M. S. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 1983;98:241–260. doi: 10.1016/0076-6879(83)98152-1. [DOI] [PubMed] [Google Scholar]
  14. Hawkins C. L., Davies M. J. Generation and propagation of radical reactions on proteins. Biochim Biophys Acta. 2001 Apr 2;1504(2-3):196–219. doi: 10.1016/s0005-2728(00)00252-8. [DOI] [PubMed] [Google Scholar]
  15. Hawkins C. L., Davies M. J. Hypochlorite-induced damage to proteins: formation of nitrogen-centred radicals from lysine residues and their role in protein fragmentation. Biochem J. 1998 Jun 15;332(Pt 3):617–625. doi: 10.1042/bj3320617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hawkins C. L., Davies M. J. Hypochlorite-induced oxidation of proteins in plasma: formation of chloramines and nitrogen-centred radicals and their role in protein fragmentation. Biochem J. 1999 Jun 1;340(Pt 2):539–548. [PMC free article] [PubMed] [Google Scholar]
  17. Hawkins Clare L., Rees Martin D., Davies Michael J. Superoxide radicals can act synergistically with hypochlorite to induce damage to proteins. FEBS Lett. 2002 Jan 2;510(1-2):41–44. doi: 10.1016/s0014-5793(01)03226-4. [DOI] [PubMed] [Google Scholar]
  18. Hazell L. J., Arnold L., Flowers D., Waeg G., Malle E., Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest. 1996 Mar 15;97(6):1535–1544. doi: 10.1172/JCI118576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hazell L. J., Baernthaler G., Stocker R. Correlation between intima-to-media ratio, apolipoprotein B-100, myeloperoxidase, and hypochlorite-oxidized proteins in human atherosclerosis. Free Radic Biol Med. 2001 Nov 15;31(10):1254–1262. doi: 10.1016/s0891-5849(01)00717-1. [DOI] [PubMed] [Google Scholar]
  20. Hazen S. L., Heinecke J. W. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest. 1997 May 1;99(9):2075–2081. doi: 10.1172/JCI119379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Heinecke J. W., Li W., Daehnke H. L., 3rd, Goldstein J. A. Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J Biol Chem. 1993 Feb 25;268(6):4069–4077. [PubMed] [Google Scholar]
  22. Heinecke J. W., Li W., Francis G. A., Goldstein J. A. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J Clin Invest. 1993 Jun;91(6):2866–2872. doi: 10.1172/JCI116531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Heinecke J. W. Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders. J Lab Clin Med. 1999 Apr;133(4):321–325. doi: 10.1016/s0022-2143(99)90061-6. [DOI] [PubMed] [Google Scholar]
  24. Heinecke J. W. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis. 1998 Nov;141(1):1–15. doi: 10.1016/s0021-9150(98)00173-7. [DOI] [PubMed] [Google Scholar]
  25. Jessup W., Dean R. T., de Whalley C. V., Rankin S. M., Leake D. S. The role of oxidative modification and antioxidants in LDL metabolism and atherosclerosis. Adv Exp Med Biol. 1990;264:139–142. doi: 10.1007/978-1-4684-5730-8_20. [DOI] [PubMed] [Google Scholar]
  26. Kettle A. J. Neutrophils convert tyrosyl residues in albumin to chlorotyrosine. FEBS Lett. 1996 Jan 22;379(1):103–106. doi: 10.1016/0014-5793(95)01494-2. [DOI] [PubMed] [Google Scholar]
  27. Kramsch D. M., Franzblau C., Hollander W. Components of the protein-lipid complex of arterial elastin: their role in the retention of lipid in atherosclerotic lesions. Adv Exp Med Biol. 1974;43(0):193–210. doi: 10.1007/978-1-4684-3243-5_10. [DOI] [PubMed] [Google Scholar]
  28. Kramsch D. M., Hollander W. The interaction of serum and arterial lipoproteins with elastin of the arterial intima and its role in the lipid accumulation in atherosclerotic plaques. J Clin Invest. 1973 Feb;52(2):236–247. doi: 10.1172/JCI107180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kutter D., Devaquet P., Vanderstocken G., Paulus J. M., Marchal V., Gothot A. Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit ? Acta Haematol. 2000;104(1):10–15. doi: 10.1159/000041062. [DOI] [PubMed] [Google Scholar]
  30. LaBella F. S. Arterial mesenchyme and arteriosclerosis. Enzymic vs non-enzymic factors in the deterioration of connective tissue. Adv Exp Med Biol. 1974;43(0):377–402. doi: 10.1007/978-1-4684-3243-5_19. [DOI] [PubMed] [Google Scholar]
  31. Linton S., Davies M. J., Dean R. T. Protein oxidation and ageing. Exp Gerontol. 2001 Sep;36(9):1503–1518. doi: 10.1016/s0531-5565(01)00136-x. [DOI] [PubMed] [Google Scholar]
  32. McGowan S. E. Mechanisms of extracellular matrix proteoglycan degradation by human neutrophils. Am J Respir Cell Mol Biol. 1990 Mar;2(3):271–279. doi: 10.1165/ajrcmb/2.3.271. [DOI] [PubMed] [Google Scholar]
  33. Morin B., Davies M. J., Dean R. T. The protein oxidation product 3,4-dihydroxyphenylalanine (DOPA) mediates oxidative DNA damage. Biochem J. 1998 Mar 15;330(Pt 3):1059–1067. doi: 10.1042/bj3301059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Nikpoor B., Turecki G., Fournier C., Théroux P., Rouleau G. A. A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am Heart J. 2001 Aug;142(2):336–339. doi: 10.1067/mhj.2001.116769. [DOI] [PubMed] [Google Scholar]
  35. Parhami F., Fang Z. T., Fogelman A. M., Andalibi A., Territo M. C., Berliner J. A. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J Clin Invest. 1993 Jul;92(1):471–478. doi: 10.1172/JCI116590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Pattison D. I., Davies M. J. Absolute rate constants for the reaction of hypochlorous acid with protein side chains and peptide bonds. Chem Res Toxicol. 2001 Oct;14(10):1453–1464. doi: 10.1021/tx0155451. [DOI] [PubMed] [Google Scholar]
  37. Pattison David I., Dean Roger T., Davies Michael J. Oxidation of DNA, proteins and lipids by DOPA, protein-bound DOPA, and related catechol(amine)s. Toxicology. 2002 Aug 1;177(1):23–37. doi: 10.1016/s0300-483x(02)00193-2. [DOI] [PubMed] [Google Scholar]
  38. Rajavashisth T. B., Yamada H., Mishra N. K. Transcriptional activation of the macrophage-colony stimulating factor gene by minimally modified LDL. Involvement of nuclear factor-kappa B. Arterioscler Thromb Vasc Biol. 1995 Oct;15(10):1591–1598. doi: 10.1161/01.atv.15.10.1591. [DOI] [PubMed] [Google Scholar]
  39. Robert L., Jacob M. P., Frances C., Godeau G., Hornebeck W. Interaction between elastin and elastases and its role in the aging of the arterial wall, skin and other connective tissues. A review. Mech Ageing Dev. 1984 Dec;28(2-3):155–166. doi: 10.1016/0047-6374(84)90015-0. [DOI] [PubMed] [Google Scholar]
  40. Robert L., Robert A. M., Jacotot B. Elastin-elastase-atherosclerosis revisited. Atherosclerosis. 1998 Oct;140(2):281–295. doi: 10.1016/s0021-9150(98)00171-3. [DOI] [PubMed] [Google Scholar]
  41. Rucker R. B., Tinker D. Structure and metabolism of arterial elastin. Int Rev Exp Pathol. 1977;17:1–47. [PubMed] [Google Scholar]
  42. Stadtman E. R. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu Rev Biochem. 1993;62:797–821. doi: 10.1146/annurev.bi.62.070193.004053. [DOI] [PubMed] [Google Scholar]
  43. Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989 Apr 6;320(14):915–924. doi: 10.1056/NEJM198904063201407. [DOI] [PubMed] [Google Scholar]
  44. Steinbrecher U. P., Parthasarathy S., Leake D. S., Witztum J. L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A. 1984 Jun;81(12):3883–3887. doi: 10.1073/pnas.81.12.3883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Steinbrecher U. P., Zhang H. F., Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med. 1990;9(2):155–168. doi: 10.1016/0891-5849(90)90119-4. [DOI] [PubMed] [Google Scholar]
  46. Suarna C., Dean R. T., May J., Stocker R. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate. Arterioscler Thromb Vasc Biol. 1995 Oct;15(10):1616–1624. doi: 10.1161/01.atv.15.10.1616. [DOI] [PubMed] [Google Scholar]
  47. Underwood P. A., Bean P. A., Whitelock J. M. Inhibition of endothelial cell adhesion and proliferation by extracellular matrix from vascular smooth muscle cells: role of type V collagen. Atherosclerosis. 1998 Nov;141(1):141–152. doi: 10.1016/s0021-9150(98)00164-6. [DOI] [PubMed] [Google Scholar]
  48. Underwood P. A., Mitchell S. M., Whitelock J. M. Heparin fails to inhibit the proliferation of human vascular smooth muscle cells in the presence of human serum. J Vasc Res. 1998 Nov-Dec;35(6):449–460. doi: 10.1159/000025616. [DOI] [PubMed] [Google Scholar]
  49. Upritchard J. E., Sutherland W. H. Oxidation of heparin-treated low density lipoprotein by peroxidases. Atherosclerosis. 1999 Oct;146(2):211–219. doi: 10.1016/s0021-9150(99)00127-6. [DOI] [PubMed] [Google Scholar]
  50. Upston Joanne M., Niu Xianwa, Brown Andrew J., Mashima Ryuichi, Wang Hongjie, Senthilmohan Revathy, Kettle Anthony J., Dean Roger T., Stocker Roland. Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis. Am J Pathol. 2002 Feb;160(2):701–710. doi: 10.1016/S0002-9440(10)64890-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Vissers M. C., Winterbourn C. C. Oxidative damage to fibronectin. I. The effects of the neutrophil myeloperoxidase system and HOCl. Arch Biochem Biophys. 1991 Feb 15;285(1):53–59. doi: 10.1016/0003-9861(91)90327-f. [DOI] [PubMed] [Google Scholar]
  52. Wagner W. D., Salisbury G. J., Rowe H. A. A proposed structure of chondroitin 6-sulfate proteoglycan of human normal and adjacent atherosclerotic plaque. Arteriosclerosis. 1986 Jul-Aug;6(4):407–417. doi: 10.1161/01.atv.6.4.407. [DOI] [PubMed] [Google Scholar]
  53. Weiss S. J., Lampert M. B., Test S. T. Long-lived oxidants generated by human neutrophils: characterization and bioactivity. Science. 1983 Nov 11;222(4624):625–628. doi: 10.1126/science.6635660. [DOI] [PubMed] [Google Scholar]
  54. Zhang R., Brennan M. L., Fu X., Aviles R. J., Pearce G. L., Penn M. S., Topol E. J., Sprecher D. L., Hazen S. L. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA. 2001 Nov 7;286(17):2136–2142. doi: 10.1001/jama.286.17.2136. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES